Again using your misleading table, CF33 is targeting all solid cancers and not just bladder cancer like CG0070. CG0070 is currently in Ph3 clinical trial so they've just decided to waste 100s of millions because it's "competitive" market lol. Of course the cancer treatment market is competitive due to the market potential and why BP invest heavily for this market.
RAC
race oncology ltd
Add to My Watchlist
5.06%
!
$1.22

RAC Charts, page-1968
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.22 |
Change
-0.065(5.06%) |
Mkt cap ! $211.9M |
Open | High | Low | Value | Volume |
$1.29 | $1.29 | $1.21 | $205.4K | 165.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 788 | $1.22 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.23 | 42 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 788 | 1.220 |
1 | 3223 | 1.210 |
4 | 26079 | 1.200 |
2 | 19167 | 1.190 |
1 | 3040 | 1.180 |
Price($) | Vol. | No. |
---|---|---|
1.230 | 42 | 1 |
1.240 | 10000 | 1 |
1.280 | 4060 | 1 |
1.300 | 2431 | 1 |
1.310 | 2360 | 1 |
Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |